Terminated PHASE2 INTERVENTIONAL 3-arm NCT00103519

Study of DITPA in Patients With Congestive Heart Failure

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DITPA in Patients With NYHA Class III and IV Congestive Heart Failure Who Have Low Serum T3 Levels

Sponsor: Titan Pharmaceuticals

Conditions Heart Failure, Congestive

Interventions DITPA (3,5-diiodothyropropionic acid) Placebo

Updated 6 times since 2017 Last updated: Mar 27, 2013 Started: Dec 31, 2004 Primary completion: Dec 31, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated for reasons unrelated to safety or efficacy.

Other terminated trials from Titan Pharmaceuticals

See all terminations from Titan Pharmaceuticals

A PHASE2 clinical study on Heart Failure, Congestive, this trial is terminated or withdrawn. The trial is conducted by Titan Pharmaceuticals and has accumulated 6 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Titan Pharmaceuticals

Data source: Titan Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Charlottesville, United States , Chicago, United States , Cincinnati, United States , Cleveland, United States , Dallas, United States , Hershey, United States , Huntsville, United States , Los Angeles, United States , Louisville, United States and 11 more locations